FGFR as potential target in the treatment of squamous non small cell lung cancer.
about
Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy.Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.A network-based method for identifying prognostic gene modules in lung squamous carcinoma.FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies.Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.Targeting FGFR in Squamous Cell Carcinoma of the Lung.Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma.Lung Cancer Biomarkers.Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinomaEmerging roles of FGF signaling in hepatocellular carcinoma.Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer.RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.Recent advances in squamous non-small cell lung cancer: evidence beyond predictive biomarkers.Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report.
P2860
Q33586758-5BF1EE2A-8AA7-4D56-B59D-A441BFF40415Q35842078-B586F9B6-5E12-43A9-9A04-FCF558EF0DA7Q37109663-098125B9-E77F-4117-A018-6211D392F075Q37164249-EA6A366D-405A-46BA-A4F0-FBB2A2F2D1B8Q37175328-37924F03-12F9-4DBE-AC75-BE64D903EA51Q37462489-FD155736-6927-4E96-B384-2100B0B1774FQ37636947-8BBBFABB-1240-4B3E-B3E7-1AF9E619379FQ38690050-0FE6264E-1565-43CA-8541-51BAD68FB163Q38705330-7D6CAC55-B4BC-4342-A0C0-DD76B109D879Q39027394-55055AD1-A8C5-44A7-B603-635343571E25Q39924228-DD897E25-5294-49F4-A6F2-D0751DA4C956Q41876265-76E1025D-B5F6-4C86-8CB3-22D2C4DBD744Q47135891-C8A07387-71C4-4719-99EF-B463FDF1DC92Q47285585-44C06B73-C64D-455A-A0EA-E5711F6F61A1Q47917013-987D6822-DCB2-45CA-9AF3-1F0CE1B2504CQ48360381-A2128D4C-8023-44D4-83F2-EEBA615442DCQ52665438-3D05E95C-F936-4EFC-9881-E1224CFBA05EQ53128013-2E8AE24E-EF12-4845-8E2B-AC37778DBBB1Q55313166-85D4DBBE-EDF5-40BD-A609-E882542B0444
P2860
FGFR as potential target in the treatment of squamous non small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FGFR as potential target in the treatment of squamous non small cell lung cancer.
@en
type
label
FGFR as potential target in the treatment of squamous non small cell lung cancer.
@en
prefLabel
FGFR as potential target in the treatment of squamous non small cell lung cancer.
@en
P2093
P50
P1476
FGFR as potential target in the treatment of squamous non small cell lung cancer.
@en
P2093
Andrea Ardizzoni
Anna Maria De Giorgi
Cecilia Bozzetti
Pier Giorgio Petronini
Roberta Alfieri
P304
P356
10.1016/J.CTRV.2015.04.011
P577
2015-05-01T00:00:00Z